Eviplera HIV drug. Person holding a box containing tablets of the combination drug emtricitabine/rilpivirine/tenofovir, marketed under the name Eviple
Eviplera HIV drug. Person holding a box containing tablets of the combination drug emtricitabine/rilpivirine/tenofovir, marketed under the name Eviplera. This drug is a nucleoside reverse transcriptase inhibitor, used as a part of antiretroviral therapy in the treatment of HIV (human immunodeficiency virus). It slows the spread of HIV (human immunodeficiency virus) in the body by inhibiting reverse transcriptase, the enzyme that converts HIV RNA (ribonucleic acid) into viral DNA (deoxyribonucleic acid) that can be incorporated into human cells.
Size: 4931px × 3945px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: 21st, acquired, adult, aids, antiretroviral, box, boxed, caucasian, century, close-, deficiency, detail, drug, drugs, emtricitabine, emtricitabine/rilpivirine/tenofovir, film-coated, hand, hands, healthcare, hiv, holding, human, immune, immunodeficiency, inhibitor, label, labeled, labelled, labels, medical, medication, medicine, nrti, nucleoside, oral, packaged, packaging, packet, people, person, pharmaceutic, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pills, prescribed, prescription, reverse, rilpivirine, syndrome, tablet, tablets, tenofovir, transcriptase, treatment, virus, white
